Research map: PARP inhibition induces a redox-dependent dormant reservoir vulnerable to disulfiram in high-grade serous ovarian cancer

Back to the article

Papers in this map

  1. The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation · Davide Chicco · 2021 · 5344 citations · Cited by this paper
  2. 2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism · 2026 · Related
  3. Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers · Peter C.C. Fong · 2009 · 3671 citations · Cited by this paper
  4. Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia · 2026 · Related
  5. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial · Robert Louis Coleman · 2017 · 1728 citations · Cited by this paper
  6. Tailoring pH-responsive charge-conversional interfaces in ionizable lipid-based nanoliposomes for synchronized co-delivery and synergistic therapy of triple-negative breast cancer · 2026 · Related
  7. MYC Activation Is a Hallmark of Cancer Initiation and Maintenance · M. Gabay · 2014 · 862 citations · Cited by this paper
  8. Preserved motor function and prolonged sensory local anesthesia with novel PLGA microparticles co-encapsulating lidocaine and capsaicin · 2026 · Related
  9. SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples · Aleksandr Ianevski · 2022 · 815 citations · Cited by this paper
  10. Iron–quercetin complex induces ex vivo proteomic remodeling in circulating proangiogenic cells derived from human peripheral blood mononuclear cells · 2026 · Related
  11. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs · Marc A. Hafner · 2016 · 757 citations · Cited by this paper
  12. Acetonic extract of Saskatoon berry attenuates amyloid-associated neurotoxicity in cellular and Drosophila melanogaster Alzheimer’s disease models · 2026 · Related
  13. Understanding and overcoming resistance to PARP inhibitors in cancer therapy · Mariana Paes Dias · 2021 · 511 citations · Cited by this paper
  14. Design of sunflower trypsin inhibitor 1 derived probes targeting the LDLR and evaluation of their brain delivery · 2026 · Related
  15. Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial · Paul DiSilvestro · 2022 · 510 citations · Cited by this paper
  16. The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts · 2026 · Related
  17. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial · Susana Banerjee · 2021 · 386 citations · Cited by this paper
  18. Urinary biomarkers in muscle-invasive bladder cancer: Current state and open opportunities for neoadjuvant chemotherapy response prediction and patient stratification · 2026 · Related
  19. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells · Alysha K. Croker · 2011 · 334 citations · Cited by this paper
  20. Fluorinated isoindolinone–amino acid hybrids possessing antiproliferative and antitumor activity in vitro and in vivo · 2026 · Related
  21. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma · Shuang Zhang · 2019 · 244 citations · Cited by this paper
  22. Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence · Hubert Fleury · 2019 · 229 citations · Cited by this paper
  23. Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy · Masashi Mikubo · 2021 · 219 citations · Cited by this paper
  24. L1000FWD: fireworks visualization of drug-induced transcriptomic signatures · Zichen Wang · 2018 · 208 citations · Cited by this paper
  25. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial · B.J. Monk · 2024 · 176 citations · Cited by this paper
  26. N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes · Cynthia A. Morgan · 2014 · 143 citations · Cited by this paper
  27. Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer · Alison E. Freimund · 2018 · 141 citations · Cited by this paper
  28. AMPK–mTOR–Mediated Activation of Autophagy Promotes Formation of Dormant Polyploid Giant Cancer Cells · Bo You · 2021 · 103 citations · Cited by this paper
  29. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer · J.E. Stine · 2015 · 94 citations · Cited by this paper
  30. Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer · Xudong Zhang · 2023 · 94 citations · Cited by this paper
  31. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines · Zhijun Yang · 2019 · 87 citations · Cited by this paper
  32. Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance · Michele Zanoni · 2022 · 84 citations · Cited by this paper
  33. C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer · Stephanie L. Wethington · 2023 · 84 citations · Cited by this paper
  34. When breaks get hot: inflammatory signaling in BRCA1/2-mutant cancers · Marcel A.T.M. van Vugt · 2022 · 61 citations · Cited by this paper
  35. Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer · Fernando Pérez‐Villatoro · 2022 · 52 citations · Cited by this paper
  36. Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasis · Yuqi Jiao · 2024 · 52 citations · Cited by this paper
  37. The molecular mechanisms of diapause and diapause-like reversible arrest · Sreesankar Easwaran · 2023 · 49 citations · Cited by this paper
  38. Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells · Sajjeev Jaganathan · 2014 · 46 citations · Cited by this paper
  39. Update on Combination Strategies of PARP Inhibitors · Zhuoqun Lin · 2024 · 32 citations · Cited by this paper

Source: OpenAlex (CC0)